Article

Time-resolved coherent anti-Stokes Raman scattering microscopy: Imaging based on Raman free induction decay

Harvard University, Department of Chemistry and Chemical Biology, 12 Oxford Street, Cambridge, Massachusetts 02138
Applied Physics Letters (Impact Factor: 3.52). 04/2002; 80(9):1505 - 1507. DOI: 10.1063/1.1456262
Source: IEEE Xplore

ABSTRACT A time-resolved coherent anti-Stokes Raman scattering (CARS) microscope allows three-dimensional imaging based on Raman free induction decay of molecular vibration with no requirement for labeling of the sample with natural or artificial fluorophores. A major benefit of the technique is the capability to completely remove nonresonant coherent background signal from the sample and the solvent, and thus increasing the detection sensitivity of CARS microscopy significantly. © 2002 American Institute of Physics.

0 Followers
 · 
75 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We demonstrate a system for the phase-resolved epi-detection of coherent anti-Stokes Raman scattering (CARS) signals in highly scattering and/or thick samples. With this setup, we measure the complex vibrational responses of multiple components in a thick, highly-scattering pharmaceutical tablet in real time and verify that the epi- and forward-detected information are in very good agreement.
    Optics Letters 10/2014; 39(20). DOI:10.1364/OL.39.005814
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Free induction decay is the coherent emission of light that follows the excitation of a medium by a short pulse. During the coherence time of the medium ($T_2$), all atoms/molecules oscillate 'in unison', forming a macroscopic dipole that emits light as a large coherent antenna, 'broadcasting' information on the quantum state of the atoms/molecules and its dynamical evolution. We present an optical oscillator, where the coherent dipole emission from a dynamical wave-packet, is amplified beyond the lasing threshold. By placing a molecular medium in an optical cavity that is synchronously pumped by a frequency comb laser, emission from the excitation of one pump pulse can return to the medium with subsequent pump pulses, allowing stimulated amplification. When threshold is crossed, a broadband coherent oscillation is achieved, bearing information on the coherent wave-packet dynamics inside the medium. We analyze theoretically this coherent Raman oscillator and simulate thoroughly it's dynamics under most realistic conditions for a model system of Alkali dimers ($Li_2, K_2$) in a hot gas cell ($100-300^{\circ}C$), showing that the oscillation condition is well within reach. If realized, this coherent Raman oscillator can open avenues for precise measurement of vibrational dynamics in molecules.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-linear optics encompasses a range of optical phenomena, including two- and three-photon fluorescence, second harmonic generation (SHG), sum frequency generation (SFG), difference frequency generation (DFG), third harmonic generation (THG), coherent anti-Stokes Raman scattering (CARS), and stimulated Raman scattering (SRS). The combined advantages of using these phenomena for imaging complex pharmaceutical systems include chemical and structural specificities, high optical spatial and temporal resolutions, no requirement for labels, and the ability to image in an aqueous environment. These features make such imaging well suited for a wide range of pharmaceutical and biopharmaceutical investigations, including material and dosage form characterisation, dosage form digestion and drug release, and drug and nanoparticle distribution in tissues and within live cells. In this review, non-linear optical phenomena used in imaging will be introduced, together with their advantages and disadvantages in the pharmaceutical context. Research on pharmaceutical and biopharmaceutical applications is discussed, and potential future applications of the technology are considered.
    International Journal of Pharmaceutics 12/2010; 417(1-2):163-72. DOI:10.1016/j.ijpharm.2010.12.017

Preview

Download
1 Download
Available from